A Study to Learn About the Study Medicine Called PF-07293893 in Healthy Adults, and How Different Doses of Study Medicine are Tolerated and Act in the Body.
This research is looking at a new medicine, called PF-07293893, for people who might someday have a type of heart condition known as heart failure with preserved ejection fraction (HFpEF). For this first stage of testing, healthy adults will be given the medicine. The main goals are to see how different amounts of the medicine work in the body, how well people tolerate it, and if it causes any unwanted effects. This is a very early step in drug development, meaning it’s the first time this specific medicine is being given to humans. It’s important to find out this information before it can be tested in people who actually have the condition.
At a glance
What is this study about?
This study is about a new medicine called PF-07293893. Doctors are hoping this medicine could help people with a condition called heart failure with preserved ejection fraction, or HFpEF. In simple terms, HFpEF means the heart can still pump blood out, but it’s become stiff and doesn't fill with blood as well as it should. This can make people feel very tired and breathless.
Because this is a brand new medicine, it’s crucial to understand how it behaves in the human body before giving it to people who are unwell. This particular study is the very first time this medicine will be given to people. It's designed to learn about how different amounts, or 'doses,' of the medicine are processed by the body and if they are safe and well-tolerated. Think of it as a careful first step to gather basic information.
By carefully studying healthy volunteers, researchers can learn important details like how much of the medicine stays in the body, how quickly it leaves, and what side effects might occur at different doses. This information is absolutely essential for deciding if and how to continue testing the medicine in the future, potentially for people living with HFpEF.
Key takeaways
- This study is testing a new medicine (PF-07293893) for the first time in people.
- It aims to understand safety and how the medicine works in healthy adults.
- It's a 'Phase I' study, focused on early safety information.
- You must be a healthy adult, aged 18 or older, to participate.
- Participation involves clinic visits, assessments, and close monitoring.
- There are no direct personal health benefits expected for participants.
Who may be eligible?
To join this study, you need to be a healthy adult aged 18 or over. This means you generally don’t have any major ongoing health problems.
Both men and women are welcome to take part in this research. The study team will check your health carefully to make sure it's safe for you to participate.
They will speak with you in detail about your health and medical history to make sure you fit all the requirements for the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally in good health?
- Have you been diagnosed with any serious ongoing medical conditions?
- Are you comfortable with regular clinic visits and medical tests?
- Are you a man or a woman?
What does participation involve?
If you decide to take part, you would receive the study medicine, PF-07293893. This is typically given in a special clinic setting where doctors and nurses can monitor you closely. You'll have several visits to the clinic, which will involve check-ups, blood tests, and other assessments to see how your body is reacting to the medicine.
The study team will carefully explain the schedule of visits, what will happen at each visit, and how long you might need to stay at the clinic for certain procedures. There will also be follow-up appointments after you stop taking the medicine to make sure you are doing well. The total time you'd be involved in the study will be clearly outlined to you during the consent process.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is the medicine PF-07293893?
It's a new medicine being tested for the first time in people, eventually hoped to help with a heart condition called HFpEF.
Why are healthy people needed for this study?
Because it’s a new medicine, researchers first need to understand how it works and if it's safe in healthy individuals before testing it in patients who are unwell.
Will I get the medicine for free?
Yes, any medicine given as part of a clinical trial is always provided free of charge.
What exactly does 'Phase I' mean?
Phase I means it's the very first time humans are receiving this specific medicine. The main goals are to check safety and how the body handles it.
Will I be compensated for taking part?
Many early-stage studies offer compensation for your time and travel, but you should ask the study team for specific details.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.